Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lodotra modified-release prednisolone vs placebo in rheumatoid arthritis
2007-003508-36Phase 3Completed
- Sponsor
- Nitec Pharma
- Start
- Feb 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Lodotra 5 mg MR prednisone with Placebo (2 arms). Primary endpoint: ACR20 response at 12 weeks. Started Feb 2008; status: completed.
02
Drugs
prednisone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-003508-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003508-36.